Indexing Narcotics, Fentanyl, and Opioids Act of 2017

Summary: Indexing Narcotics, Fentanyl, and Opioids Act of 2017 or the INFO Act This bill requires the Secretary of Health and Human Services&nbsp;to appoint a federal coordinator&nbsp;within the Department of Health and Human Services to:  coordinate&nbsp;programs related to opioid abuse reduction, liaise with state and local entities carrying out activities relating to opioid abuse reduction, and  establish and operate a publicly available electronic database&nbsp;to facilitate&nbsp;data collection&nbsp;related to&nbsp;opioid abuse.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Indexing Narcotics, Fentanyl, and 
Opioids Act of 2018'' or the ``INFO Act''.

SEC. 2. ESTABLISHMENT OF SUBSTANCE USE DISORDER INFORMATION DASHBOARD.

    Title XVII of the Public Health Service Act (42 U.S.C. 300u et 
seq.) is amended by adding at the end the following new section:

``SEC. 1711. ESTABLISHMENT OF SUBSTANCE USE DISORDER INFORMATION 
              DASHBOARD.

    ``(a) In General.--Not later than 6 months after the date of the 
enactment of this section, the Secretary of Health and Human Services 
shall, in consultation with the Director of National Drug Control 
Policy, establish and periodically update a public information 
dashboard that--
            ``(1) coordinates information on programs within the 
        Department of Health and Human Services related to the 
        reduction of opioid abuse and other substance use disorders;
            ``(2) provides access to publicly available data from other 
        Federal agencies; State, local, and Tribal governments; 
        nonprofit organizations; law enforcement; medical experts; 
        public health educators; and research institutions regarding 
        prevention, treatment, recovery, and other services for opioid 
        use disorder and other substance use disorders;
            ``(3) provides comparable data on substance use disorder 
        prevention and treatment strategies in different regions and 
        population of the United States;
            ``(4) provides recommendations for health care providers on 
        alternatives to controlled substances for pain management, 
        including approaches studied by the National Institutes of 
        Health Pain Consortium and the National Center for 
        Complimentary and Integrative Health; and
            ``(5) provides guidelines and best practices for health 
        care providers regarding treatment of substance use disorders.
    ``(b) Controlled Substance Defined.--In this section, the term 
`controlled substance' has the meaning given that term in section 102 
of the Controlled Substances Act (21 U.S.C. 802).''.

SEC. 3. INTERAGENCY SUBSTANCE USE DISORDER COORDINATING COMMITTEE.

    (a) Establishment.--Not later than 3 months after the date of the 
enactment of this Act, the Secretary of Health and Human Services (in 
this section referred to as the ``Secretary'') shall, in consultation 
with the Director of National Drug Control Policy, establish a 
committee, to be known as the Interagency Substance Use Disorder 
Coordinating Committee (in this section referred to as the 
``Committee''), to coordinate all efforts within the Department of 
Health and Human Services concerning substance use disorder.
    (b) Membership.--
            (1) Federal members.--The following individuals shall be 
        the Federal members of the Committee:
                    (A) The Secretary, who shall service as the Chair 
                of the Committee.
                    (B) The Attorney General of the United States.
                    (C) The Secretary of Labor.
                    (D) The Secretary of Housing and Urban Development.
                    (E) The Secretary of Education.
                    (F) The Secretary of Veterans Affairs.
                    (G) The Commissioner of Social Security.
                    (H) The Assistant Secretary for Mental Health and 
                Substance Use.
                    (I) The Director of the Centers for Disease Control 
                and Prevention.
                    (J) The Director of the National Institutes of 
                Health and the Directors of such national research 
                institutes of the National Institutes of Health as the 
                Secretary determines appropriate.
                    (K) The Administrator of the Centers for Medicare & 
                Medicaid Services.
                    (L) The Director of National Drug Control Policy.
                    (M) Representatives of other Federal agencies that 
                serve individuals with substance use disorder.
            (2) Non-federal members.--The Committee shall include a 
        minimum of 17 non-Federal members appointed by the Secretary, 
        of which--
                    (A) at least two such members shall be an 
                individual who has received treatment for a diagnosis 
                of an opioid use disorder;
                    (B) at least two such members shall be an 
                individual who has received treatment for a diagnosis 
                of a substance use disorder other than an opioid use 
                disorder;
                    (C) at least two such members shall be a State 
                Alcohol and Substance Abuse Director;
                    (D) at least two such members shall be a 
                representative of a leading research, advocacy, or 
                service organization for adults with substance use 
                disorder;
                    (E) at least two such members shall--
                            (i) be a physician, licensed mental health 
                        professional, advance practice registered 
                        nurse, or physician assistant; and
                            (ii) have experience in treating 
                        individuals with opioid use disorder or other 
                        substance use disorders;
                    (F) at least one such member shall be a substance 
                use disorder treatment professional who is employed 
                with an opioid treatment program;
                    (G) at least one such member shall be a substance 
                use disorder treatment professional who has research or 
                clinical experience in working with racial and ethnic 
                minority populations;
                    (H) at least one such member shall be a substance 
                use disorder treatment professional who has research or 
                clinical mental health experience in working with 
                medically underserved populations;
                    (I) at least one such member shall be a State-
                certified substance use disorder peer support 
                specialist;
                    (J) at least one such member shall be a drug court 
                judge or a judge with experience in adjudicating cases 
                related to substance use disorder;
                    (K) at least one such member shall be a law 
                enforcement officer or correctional officer with 
                extensive experience in interacting with adults with a 
                substance use disorder; and
                    (L) at least one such member shall be an individual 
                with experience providing services for homeless 
                individuals and working with adults with a substance 
                use disorder.
    (c) Terms.--
            (1) In general.--A member of the Committee appointed under 
        subsection (b)(2) shall be appointed for a term of 3 years and 
        may be reappointed for one or more 3-year terms.
            (2) Vacancies.--A vacancy on the Committee shall be filled 
        in the same manner in which the original appointment was made. 
        Any individual appointed to fill a vacancy for an unexpired 
        term shall be appointed for the remainder of such term and may 
        serve after the expiration of such term until a successor has 
        been appointed.
    (d) Meetings.--The Committee shall meet not fewer than two times 
each year.
    (e) Duties.--The Committee shall--
            (1) monitor opioid use disorder and other substance use 
        disorder research, services, and support and prevention 
        activities across all relevant Federal agencies, including 
        coordination of Federal activities with respect to opioid use 
        disorder and other substance use disorders;
            (2) identify and provide to the Secretary recommendations 
        for improving Federal grants and programs for the prevention 
        and treatment of, and recovery from, opioid use disorder and 
        other substance use disorders;
            (3) review substance use disorder prevention and treatment 
        strategies in different regions and populations in the United 
        States and evaluate the extent to which Federal substance use 
        disorder prevention and treatment strategies are aligned with 
        State and local substance use disorder prevention and treatment 
        strategies;
            (4) make recommendations to the Secretary regarding any 
        appropriate changes with respect to the activities and 
        strategies described in paragraphs (1) through (3);
            (5) make recommendations to the Secretary regarding public 
        participation in decisions relating to opioid use disorder and 
        other substance use disorders and the process by which public 
        feedback can be better integrated into such decisions; and
            (6) make recommendations to ensure that opioid use disorder 
        and other substance use disorder research, services, and 
        support and prevention activities of the Department of Health 
        and Human Services and other Federal agencies are not 
        unnecessarily duplicative.
    (f) Annual Report.--
            (1) In general.--Not later than 1 year after the date of 
        the enactment of this Act, and annually thereafter for the life 
        of the Committee, the Committee shall publish on the public 
        information dashboard established under section 2(a) a report 
        summarizing the activities carried out by the Committee 
        pursuant to subsection (e), including any findings resulting 
        from such activities.
            (2) Recommendation for committee extension.--After the 
        publication of the second report of the Committee under 
        paragraph (1), the Secretary shall submit to Congress a 
        recommendation on whether or not the operations of the 
        Committee should continue after the termination date described 
        in subsection (i).
    (g) Working Groups.--The Committee may establish working groups for 
purposes of carrying out the duties described in subsection (e). Any 
such working group shall be composed of members of the Committee (or 
the designees of such members) and may hold such meetings as are 
necessary to enable the working group to carry out the duties delegated 
to the working group.
    (h) Federal Advisory Committee Act.--The Federal Advisory Committee 
Act (5 U.S.C. App.) shall apply to the Committee only to the extent 
that the provisions of such Act do not conflict with the requirements 
of this section.
    (i) Sunset.--The Committee shall terminate on the date that is 6 
years after the date on which the Committee is established under 
subsection (a).

            Passed the House of Representatives June 12, 2018.

            Attest:

                                                 KAREN L. HAAS,

                                                                 Clerk.